BF Biosciences Limited (PSX:BFBIO)
157.27
-6.74 (-4.11%)
At close: Feb 19, 2026
-19.74% (1Y)
| Market Cap | 13.89B -26.3% |
| Revenue (ttm) | 6.88B +68.7% |
| Net Income | 491.40M +22.9% |
| EPS | 5.64 -10.8% |
| Shares Out | 88.33M |
| PE Ratio | 27.90 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 174,945 |
| Average Volume | 962,802 |
| Open | 165.00 |
| Previous Close | 164.01 |
| Day's Range | 155.10 - 165.48 |
| 52-Week Range | 117.00 - 204.39 |
| Beta | n/a |
| RSI | 45.46 |
| Earnings Date | Feb 25, 2026 |